Production (Stage)
Emmaus Life Sciences, Inc.
EMMA
$0.017
$0.000.00%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -4.44M | -6.45M | -3.50M | -5.26M | -4.63M |
| Total Depreciation and Amortization | 21.00K | 22.00K | 23.00K | 26.00K | 29.00K |
| Total Amortization of Deferred Charges | 313.00K | 708.00K | 1.35M | 1.87M | 2.48M |
| Total Other Non-Cash Items | -553.00K | -763.00K | -1.76M | -1.60M | -181.00K |
| Change in Net Operating Assets | 2.51M | 4.20M | 2.29M | 3.28M | 2.23M |
| Cash from Operations | -2.15M | -2.29M | -1.59M | -1.68M | -71.00K |
| Capital Expenditure | -8.00K | -12.00K | -12.00K | -13.00K | -15.00K |
| Sale of Property, Plant, and Equipment | 4.00K | 4.00K | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 2.51M | 2.51M | 2.51M | 2.11M | 670.00K |
| Cash from Investing | 2.50M | 2.50M | 2.50M | 2.10M | 655.00K |
| Total Debt Issued | 3.92M | 4.11M | 5.25M | 8.70M | 8.67M |
| Total Debt Repaid | -4.66M | -5.46M | -6.41M | -8.93M | -9.29M |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -743.00K | -1.35M | -1.16M | -231.00K | -619.00K |
| Foreign Exchange rate Adjustments | 7.00K | -19.00K | 10.00K | -18.00K | -27.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -379.00K | -1.16M | -250.00K | 164.00K | -62.00K |